In a recent article, The Association of Clinical Research Organizations (ACRO) has voiced its concern that the Sunshine Act may have negative effects on US drug research. The Sunshine Act requires the reporting of payments made by biopharma to physicians and was designed to increase transparency, but many physicians believe that the results could be misinterpreted and misunderstood which is causing organizations such as ACRO to be very cautious of the Sunshine Act. To read more, click here.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Pearl IRB 2023 Year-End Schedule
Snowball Sampling: Is it ethical to pay your study subjects to recruit participants on your behalf?
Improving Exempt Submissions: 7 Tips to Reduce Revision Requests
Common Rule Exceptions to the Use of a Single IRB for Multi-site Research Ends After May 11, 2023
Pearl IRB 2022 Year-End Schedule